BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 29026809)

  • 1. Spontaneously Resolved Macrocystic Lymphatic Malformations: Predictive Variables and Outcomes.
    Phang MJ; Courtemanche DJ; Bucevska M; Malic C; Arneja JS
    Plast Surg (Oakv); 2017 Feb; 25(1):27-31. PubMed ID: 29026809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous ultrasound-guided sclerotherapy with polidocanol microfoam for lymphatic malformations.
    Yamaki T; Sasaki Y; Hasegawa Y; Osada A; Konoeda H; Hamahata A; Nozaki M; Sakurai H
    J Vasc Surg Venous Lymphat Disord; 2017 Sep; 5(5):707-714. PubMed ID: 28818226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
    Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
    J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of lymphatic malformations in oral and maxillofacial regions: the rationale according to the new classification].
    Zheng JW; Qin ZP; Zhang ZY
    Shanghai Kou Qiang Yi Xue; 2005 Dec; 14(6):553-6. PubMed ID: 16400476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional injection of Pingyangmycin for vascular malformations in oral and maxillofacial regions: an evaluation of 297 consecutive patients.
    Zheng JW; Yang XJ; Wang YA; He Y; Ye WM; Zhang ZY
    Oral Oncol; 2009 Oct; 45(10):872-6. PubMed ID: 19628423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous sclerotherapy of massive macrocystic lymphatic malformations of the face and neck using fibrin glue with OK-432 and bleomycin.
    Chen WL; Huang ZQ; Chai Q; Zhang DM; Wang YY; Wang HJ; Wang L; Fan S
    Int J Oral Maxillofac Surg; 2011 Jun; 40(6):572-6. PubMed ID: 21367582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxycycline sclerotherapy as primary treatment of head and neck lymphatic malformations in children.
    Nehra D; Jacobson L; Barnes P; Mallory B; Albanese CT; Sylvester KG
    J Pediatr Surg; 2008 Mar; 43(3):451-60. PubMed ID: 18358281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with lymphatic malformations who receive the immunostimulant OK-432 experience excellent long-term outcomes.
    Ghaffarpour N; Petrini B; Svensson LA; Boman K; Wester T; Claesson G
    Acta Paediatr; 2015 Nov; 104(11):1169-73. PubMed ID: 26081020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxycycline sclerotherapy for pediatric head and neck macrocystic lymphatic malformations: a case series and review of the literature.
    Jamal N; Ahmed S; Miller T; Bent J; Brook A; Parikh S; Ankola A
    Int J Pediatr Otorhinolaryngol; 2012 Aug; 76(8):1127-31. PubMed ID: 22572407
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Percutaneous drainage and ablation as first line therapy for macrocystic and microcystic orbital lymphatic malformations.
    Hill RH; Shiels WE; Foster JA; Czyz CN; Stacey A; Everman KR; Cahill KV
    Ophthalmic Plast Reconstr Surg; 2012; 28(2):119-25. PubMed ID: 22366666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Noninterventional treatment of selected head and neck lymphatic malformations.
    Dasgupta R; Adams D; Elluru R; Wentzel MS; Azizkhan RG
    J Pediatr Surg; 2008 May; 43(5):869-73. PubMed ID: 18485956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Symptom Resolution and Volumetric Reduction of Abdominal Lymphatic Malformations With Sclerotherapy.
    Madsen HJ; Annam A; Harned R; Nakano TA; Larroque LO; Kulungowski AM
    J Surg Res; 2019 Jan; 233():256-261. PubMed ID: 30502256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization of lymphatic malformations of the neck.
    Wiegand S; Ott A; Zimmermann AP; Wilhelm T; Eivazi B; Werner JA
    Lymphat Res Biol; 2013 Jun; 11(2):101-3. PubMed ID: 23772719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy for lymphatic malformations of the head and neck in the pediatric population.
    Tu JH; Do HM; Patel V; Yeom KW; Teng JMC
    J Neurointerv Surg; 2017 Oct; 9(10):1023-1026. PubMed ID: 27707871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An 8-year population description from a national treatment centre on lymphatic malformations.
    Eliasson JJ; Weiss I; Høgevold HE; Oliver N; Andersen R; Try K; Tønseth KA
    J Plast Surg Hand Surg; 2017 Aug; 51(4):280-285. PubMed ID: 27846771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional bleomycin injection in management of low flow vascular malformations in children.
    Mohan AT; Adams S; Adams K; Hudson DA
    J Plast Surg Hand Surg; 2015 Apr; 49(2):116-20. PubMed ID: 25204206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical excision as primary treatment modality for extensive cervicofacial lymphatic malformations in children.
    Bajaj Y; Hewitt R; Ifeacho S; Hartley BE
    Int J Pediatr Otorhinolaryngol; 2011 May; 75(5):673-7. PubMed ID: 21419500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of Injection Sclerotherapy with Bleomycin in Pediatric Lymphatic Malformations.
    Kumar V; Choudhury SR; Yadav PS; Khanna V; Gupta A; Chadha R; Anand R
    J Indian Assoc Pediatr Surg; 2021; 26(4):223-227. PubMed ID: 34385764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphatic malformations: diagnosis and management.
    Elluru RG; Balakrishnan K; Padua HM
    Semin Pediatr Surg; 2014 Aug; 23(4):178-85. PubMed ID: 25241095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of the low-flow head and neck vascular malformations in children: the sclerotherapy protocol.
    Leung M; Leung L; Fung D; Poon WL; Liu C; Chung K; Tang P; Tse S; Fan TW; Chao N; Liu K
    Eur J Pediatr Surg; 2014 Feb; 24(1):97-101. PubMed ID: 24008546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.